Honasa Consumer Share Price in Focus; Calls Off Proposed Acquisition of 58% Stake in Fluence Pharma

On August 25, 2026, Honasa Consumer Limited, known for its brand Mamaearth, announced the cancellation of its proposed acquisition of a 58% equity stake in Fluence Pharma Private Limited, as per the exchange filings.  

This decision was made on August 25, 2026, due to the non-fulfilment of closing conditions outlined in the Share Purchase Agreement. 

Details of the Cancelled Acquisition 

Initially announced on June 23, 2026, the acquisition was subject to certain conditions precedent. However, as these conditions were not met, Honasa Consumer decided to call off the deal.  

The company had aimed to enhance its presence in the nutraceutical sector through this acquisition. 

The company remains committed to its strategy in the nutraceutical sector and will continue exploring both organic and inorganic opportunities to strengthen its consumer-focused business. 

Company's Future Strategy 

Despite the cancellation, Honasa Consumer remains dedicated to its growth strategy in the nutraceutical sector.  

The company is evaluating various opportunities to build a robust consumer-focused business in this category, ensuring alignment with its long-term goals. 

Also Check: Trading Stocks

Honasa Consumer Q1 FY27 Earnings  

For the quarter ending June 30, 2026, Honasa Consumer Limited's total income increased by 25.7% year-on-year (YoY) to ₹778.46 crore, up from ₹619.14 crore in the same quarter of the previous year.   

The company also saw a 15.2% quarter-on-quarter (QoQ) rise from ₹675.96 crore in the March 2026 quarter. Net profit for the June 2026 quarter rose by 118.9% YoY to ₹90.45 crore, compared to ₹41.33 crore a year ago.   

This also marks a 30.3% QoQ increase from ₹69.44 crore in the March 2026 quarter.  

Annual Performance for FY26  

For the financial year 2026, Honasa Consumer Limited's total income stood at ₹2,475.53 crore. The net profit for the year was recorded at ₹200.19 crore, reflecting the company's strong financial performance over the year. 

Read More: JSW Energy and Rongjie Energy Sign MOU for 5 GWh Energy Storage Supply! 

Honasa Consumer Share Price Performance 

As of August 26, 2026, at 10:08 AM, Honasa Consumer share price on NSE was trading at ₹481.20, down by 0.89% from the previous closing price. 

Conclusion 

On August 25, 2026, Honasa Consumer Limited cancelled its planned acquisition of a 58% stake in Fluence Pharma due to unmet conditions in the Share Purchase Agreement. The company continues to pursue opportunities in the nutraceutical sector. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Looking to invest? Open a Demat Account with Angel One and start trading seamlessly.